Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Neonatal gut and respiratory microbiota: coordinated development through time and space.

Grier A, McDavid A, Wang B, Qiu X, Java J, Bandyopadhyay S, Yang H, Holden-Wiltse J, Kessler HA, Gill AL, Huyck H, Falsey AR, Topham DJ, Scheible KM, Caserta MT, Pryhuber GS, Gill SR.

Microbiome. 2018 Oct 26;6(1):193. doi: 10.1186/s40168-018-0566-5.

2.

Impact of prematurity and nutrition on the developing gut microbiome and preterm infant growth.

Grier A, Qiu X, Bandyopadhyay S, Holden-Wiltse J, Kessler HA, Gill AL, Hamilton B, Huyck H, Misra S, Mariani TJ, Ryan RM, Scholer L, Scheible KM, Lee YH, Caserta MT, Pryhuber GS, Gill SR.

Microbiome. 2017 Dec 11;5(1):158. doi: 10.1186/s40168-017-0377-0.

3.

Relationship among knowledge acquisition, motivation to change, and self-efficacy in CME participants.

Williams BW, Kessler HA, Williams MV.

J Contin Educ Health Prof. 2015 Spring;35 Suppl 1:S13-21. doi: 10.1002/chp.21291.

PMID:
26115236
4.

Relationship among practice change, motivation, and self-efficacy.

Williams BW, Kessler HA, Williams MV.

J Contin Educ Health Prof. 2014 Spring;34 Suppl 1:S5-10. doi: 10.1002/chp.21235.

PMID:
24935884
5.

Continuity of care in a cohort of HIV-infected former jail detainees.

Khawcharoenporn T, Zawitz C, Young JD, Kessler HA.

J Correct Health Care. 2013 Jan;19(1):36-42. doi: 10.1177/1078345812458246. Epub 2012 Sep 27.

PMID:
23023657
6.

Seroprevalence study using oral rapid HIV testing in a large urban emergency department.

Jain S, Lowman ES, Kessler A, Harper J, Rumoro DP, Smith KY, Purim-Shem-Tov Y, Kessler HA.

J Emerg Med. 2012 Nov;43(5):e269-75. doi: 10.1016/j.jemermed.2012.02.021. Epub 2012 Apr 26. Erratum in: J Emerg Med. 2013 Jun;44(6):1212.

PMID:
22541880
7.

Classic pyomyositis of the extremities as an unusual manifestation of Blastomyces dermatitidis: a report of two cases.

Lin MY, Chihara S, Smith KY, Kessler HA, Sha BE, Proia LA.

Mycoses. 2010 Jul;53(4):356-9. doi: 10.1111/j.1439-0507.2009.01714.x. Epub 2009 Jun 1. Review.

PMID:
19496934
8.

White matter anisotropy and depression symptoms in patients with HIV.

Smith CA, Stebbins GT, Bartt RE, Kessler HA, Adeyemi OM, Martin E, Bammer R, Moseley ME.

J Neuropsychiatry Clin Neurosci. 2008 Fall;20(4):458-65. doi: 10.1176/appi.neuropsych.20.4.458.

PMID:
19196931
9.

Coronary artery calcification on electron beam computed tomography: a 6-year follow-up study of HIV-infected patients.

Adeyemi OM, Rezai K, Akimov S, Hwang J, Sha BE, Kessler HA.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):113-4. doi: 10.1097/QAI.0b013e31816de252. No abstract available.

PMID:
18725810
10.

HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study.

Stebbins GT, Smith CA, Bartt RE, Kessler HA, Adeyemi OM, Martin E, Cox JL, Bammer R, Moseley ME.

J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):564-73.

PMID:
18193498
11.

Herpes simplex virus hepatitis: expanding the spectrum of disease.

Duckro AN, Sha BE, Jakate S, Hayden MK, Simon DM, Saltzberg SN, Arai S, Kessler HA.

Transpl Infect Dis. 2006 Sep;8(3):171-6.

PMID:
16913977
12.

Native valve endocarditis due to Gordonia polyisoprenivorans: case report and review of literature of bloodstream infections caused by Gordonia species.

Verma P, Brown JM, Nunez VH, Morey RE, Steigerwalt AG, Pellegrini GJ, Kessler HA.

J Clin Microbiol. 2006 May;44(5):1905-8. Review.

14.

Short-term safety and pharmacodynamics of amdoxovir in HIV-infected patients.

Thompson MA, Kessler HA, Eron JJ Jr, Jacobson JM, Adda N, Shen G, Zong J, Harris J, Moxham C, Rousseau FS; DAPD-101 Study Group.

AIDS. 2005 Oct 14;19(15):1607-15.

PMID:
16184030
15.

Monitoring processed, mature Human Immunodeficiency Virus type 1 particles immediately following treatment with a protease inhibitor-containing treatment regimen.

Baird HA, Marozsan AJ, Lederman MM, Landay A, Mildvan D, Kuritzkes DR, Kessler HA, Arts EJ.

AIDS Res Ther. 2005 Apr 12;2(1):2.

16.

Triple-nucleoside analog antiretroviral therapy: is there still a role in clinical practice? A review.

Kessler HA.

J Int AIDS Soc. 2005 Jun 2;7(2):70. doi: 10.1186/1758-2652-7-2-70.

17.

Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study.

Hicks C, King MS, Gulick RM, White AC Jr, Eron JJ Jr, Kessler HA, Benson C, King KR, Murphy RL, Brun SC.

AIDS. 2004 Mar 26;18(5):775-9.

PMID:
15075512
18.

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.

Eron JJ, Feinberg J, Kessler HA, Horowitz HW, Witt MD, Carpio FF, Wheeler DA, Ruane P, Mildvan D, Yangco BG, Bertz R, Bernstein B, King MS, Sun E.

J Infect Dis. 2004 Jan 15;189(2):265-72. Epub 2004 Jan 7.

PMID:
14722892
19.

HIV-1-infected antiretroviral-treated patients with prolonged partial viral suppression: clinical, virologic, and immunologic course.

Tenorio AR, Smith KY, Kuritzkes DR, Sha BE, Donoval B, Young R, Jennings C, Bremer J, Shott S, Landay A, Kessler HA.

J Acquir Immune Defic Syndr. 2003 Dec 15;34(5):491-6.

PMID:
14657759
20.

CCR5 and CXCR4 expression after highly active antiretroviral therapy (HAART).

Smith KY, Kumar S, Pulvirenti JJ, Gianesin M, Kessler HA, Landay A.

J Acquir Immune Defic Syndr. 2002 Aug 1;30(4):458-60. No abstract available.

PMID:
12138354
21.

Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy.

Talwani R, Falusi OM, Mendes de Leon CF, Nerad JL, Rich S, Proia LA, Sha BE, Smith KY, Kessler HA.

J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):191-5.

PMID:
12045682
22.

Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection.

Gish RG, Leung NW, Wright TL, Trinh H, Lang W, Kessler HA, Fang L, Wang LH, Delehanty J, Rigney A, Mondou E, Snow A, Rousseau F.

Antimicrob Agents Chemother. 2002 Jun;46(6):1734-40.

23.

Safety and antiviral activity at 48 weeks of lopinavir/ritonavir plus nevirapine and 2 nucleoside reverse-transcriptase inhibitors in human immunodeficiency virus type 1-infected protease inhibitor-experienced patients.

Benson CA, Deeks SG, Brun SC, Gulick RM, Eron JJ, Kessler HA, Murphy RL, Hicks C, King M, Wheeler D, Feinberg J, Stryker R, Sax PE, Riddler S, Thompson M, Real K, Hsu A, Kempf D, Japour AJ, Sun E.

J Infect Dis. 2002 Mar 1;185(5):599-607. Epub 2002 Feb 14.

PMID:
11865416
24.

A pilot study of the safety and efficacy of cholestin in treating HIV-related dyslipidemia.

Keithley JK, Swanson B, Sha BE, Zeller JM, Kessler HA, Smith KY.

Nutrition. 2002 Feb;18(2):201-4.

PMID:
11844656
25.

Abacavir expanded access program for adult patients infected with human immunodeficiency virus type 1.

Kessler HA, Johnson J, Follansbee S, Sension MG, Mildvan D, Sepulveda GE, Bellos NC, Hetherington SV.

Clin Infect Dis. 2002 Feb 15;34(4):535-42. Epub 2002 Jan 4.

PMID:
11797183
26.
27.

ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results.

Murphy RL, Brun S, Hicks C, Eron JJ, Gulick R, King M, White AC Jr, Benson C, Thompson M, Kessler HA, Hammer S, Bertz R, Hsu A, Japour A, Sun E.

AIDS. 2001 Jan 5;15(1):F1-9.

PMID:
11192874
28.

Anti-CCR5 antibodies in sera of HIV-positive individuals.

Grene E, Pinto LA, Landay AL, Kessler HA, Anderson SA, Dolan MJ, Shearer GM.

Hum Immunol. 2001 Feb;62(2):143-5.

PMID:
11182224
29.

T cell responses to recall antigens, alloantigen, and mitogen of HIV-infected patients receiving long-term combined antiretroviral therapy.

Blazevic V, Sahgal N, Kessler HA, Landay AL, Shearer GM.

AIDS Res Hum Retroviruses. 2000 Nov 20;16(17):1887-93.

PMID:
11118074
30.

Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.

Sha BE, Proia LA, Kessler HA.

JAMA. 2000 Dec 6;284(21):2723. No abstract available.

PMID:
11105176
31.

Efficacy and safety of the combination of efavirenz and abacavir in HIV-infected patients failing antiretroviral therapy.

Tenorio AR, Irlanda IE, Narkiewicz E, Smith KY, Kessler HA, Sha BE.

AIDS. 2000 Jul 7;14(10):1470-1. No abstract available.

PMID:
10930173
32.

Dementia rating scale performance: a comparison of vascular and Alzheimer's dementia.

Lukatela KA, Cohen RA, Kessler HA, Jenkins MA, Moser DJ, Stone WF, Gordon NF, Kaplan RF.

J Clin Exp Neuropsychol. 2000 Aug;22(4):445-54.

PMID:
10923054
33.

Reactivation of hepatitis B in patients with human immunodeficiency virus infection treated with combination antiretroviral therapy.

Proia LA, Ngui SL, Kaur S, Kessler HA, Trenholme GM.

Am J Med. 2000 Feb 15;108(3):249-51. No abstract available.

PMID:
10723980
34.

Increased levels of anti-CCR5 antibodies in sera from individuals immunized with allogeneic lymphocytes.

Grene E, Pinto LA, Kwak-Kim JY, Giorgi JV, Landay AL, Kessler HA, Beer AE, Shearer GM.

AIDS. 2000 Nov 10;14(16):2627-8. No abstract available.

PMID:
11101084
35.

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy.

Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, Connick E, Kuritzkes D, Gross B, Francis I, McCune JM, Lederman MM.

J Infect Dis. 2000 Jan;181(1):141-7.

PMID:
10608760
36.

Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy.

Chougnet C, Cohen SS, Kawamura T, Landay AL, Kessler HA, Thomas E, Blauvelt A, Shearer GM.

J Immunol. 1999 Aug 1;163(3):1666-73.

37.

Effect of zidovudine postexposure prophylaxis on the development of HIV-specific cytotoxic T-lymphocyte responses in HIV-exposed healthcare workers.

D'Amico R, Pinto LA, Meyer P, Landay AL, Harris AA, Clerici M, Berzofsky JA, Shearer GM, Kessler HA.

Infect Control Hosp Epidemiol. 1999 Jun;20(6):428-30.

PMID:
10395147
38.

Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero.

Olivero OA, Shearer GM, Chougnet CA, Kovacs AA, Landay AL, Baker R, Stek AM, Khoury MM, Proia LA, Kessler HA, Sha BE, Tarone RE, Poirier MC.

AIDS. 1999 May 28;13(8):919-25.

PMID:
10371172
39.

Genotypic analysis of HIV-1 isolates to identify antiretroviral resistance mutations from source patients involved in health care worker occupational exposures.

Tack PC, Bremer JW, Harris AA, Landay AL, Kessler HA, Kuritzkes DR.

JAMA. 1999 Mar 24-31;281(12):1085-6. No abstract available.

PMID:
10188657
40.

Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA.

Whitley RJ, Jacobson MA, Friedberg DN, Holland GN, Jabs DA, Dieterich DT, Hardy WD, Polis MA, Deutsch TA, Feinberg J, Spector SA, Walmsley S, Drew WL, Powderly WG, Griffiths PD, Benson CA, Kessler HA.

Arch Intern Med. 1998 May 11;158(9):957-69.

PMID:
9588429
41.

CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients.

Chougnet C, Thomas E, Landay AL, Kessler HA, Buchbinder S, Scheer S, Shearer GM.

Eur J Immunol. 1998 Feb;28(2):646-56.

42.

Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients.

Fowke KR, D'Amico R, Chernoff DN, Pottage JC Jr, Benson CA, Sha BE, Kessler HA, Landay AL, Shearer GM.

AIDS. 1997 Jul;11(8):1013-21.

PMID:
9223736
43.

Immune response to human immunodeficiency virus (HIV) in healthcare workers occupationally exposed to HIV-contaminated blood.

Pinto LA, Landay AL, Berzofsky JA, Kessler HA, Shearer GM.

Am J Med. 1997 May 19;102(5B):21-4. Review.

PMID:
9845492
44.

In vitro immunologic and virologic effects of interleukin 15 on peripheral blood mononuclear cells from normal donors and human immunodeficiency virus type 1-infected patients.

Lucey DR, Pinto LA, Bethke FR, Rusnak J, Melcher GP, Hashemi FN, Landay AL, Kessler HA, Paxton RJ, Grabstein K, Shearer GM.

Clin Diagn Lab Immunol. 1997 Jan;4(1):43-8.

45.

Geographic variation in the management and outcome of patients with AIDS-related Pneumocystis carinii pneumonia.

Cohn SE, Klein JD, Weinstein RA, Shapiro MF, DeHovitz JA, Kessler HA, Dickinson GM, Rodrigue DC, Bennett CL.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Dec 15;13(5):408-15.

PMID:
8970466
46.

Contribution of prostaglandin E2 to the interleukin-12 defect in HIV-infected patients.

Chougnet CA, Margolis D, Landay AL, Kessler HA, Shearer GM.

AIDS. 1996 Aug;10(9):1043-5. No abstract available.

PMID:
8853741
47.

Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus.

Chougnet C, Wynn TA, Clerici M, Landay AL, Kessler HA, Rusnak J, Melcher GP, Sher A, Shearer GM.

J Infect Dis. 1996 Jul;174(1):46-53.

PMID:
8656012
48.

Antigen-stimulated apoptotic T-cell death in HIV infection is selective for CD4+ T cells, modulated by cytokines and effected by lymphotoxin.

Clerici M, Sarin A, Berzofsky JA, Landay AL, Kessler HA, Hashemi F, Hendrix CW, Blatt SP, Rusnak J, Dolan MJ, Coffman RL, Henkart PA, Shearer GM.

AIDS. 1996 Jun;10(6):603-11.

PMID:
8780814
49.

Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials Group.

Kessler HA, Hurwitz S, Farthing C, Benson CA, Feinberg J, Kuritzkes DR, Bailey TC, Safrin S, Steigbigel RT, Cheeseman SH, McKinley GF, Wettlaufer B, Owens S, Nevin T, Korvick JA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jun 1;12(2):147-52.

PMID:
8680885
50.

Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia.

Horner RD, Bennett CL, Rodriguez D, Weinstein RA, Kessler HA, Dickinson GM, Johnson JL, Cohn SE, George WL, Gilman SC, et al.

Am J Respir Crit Care Med. 1995 Nov;152(5 Pt 1):1435-42.

PMID:
7582274

Supplemental Content

Loading ...
Support Center